Results 211 to 220 of about 301,002 (287)
Hepatitis B Vaccine in national immunization schedule: A preventive step in India
Human Vaccines, 2011 R. Verma +5 more
semanticscholar +1 more source
COVID‐19 and Liver Injury, Beyond the First Pandemic Waves: Clinical and Immune‐Virological Features
Journal of Viral Hepatitis, Volume 32, Issue 7, July 2025.ABSTRACT A liver involvement in Coronavirus disease 19 (COVID‐19) has been frequently observed in patients hospitalised for severe acute respiratory syndrome Coronavirus 2 (SARS‐CoV‐2) infection during 2020; in such cases, the clinical and prognostic relevance of hepatocellular damage has been widely acknowledged.
Luca Foroghi Biland +10 more
wiley +1 more source
Liver International, Volume 45, Issue 7, July 2025.ABSTRACT Background and Aims SARS‐CoV‐2 vaccine‐associated liver injury (SVALI) is a rare event and its pathophysiology remains unclear. Previous studies have found an oligoclonal CD8+ T cell infiltrate and SARS‐CoV‐2 spike antigen‐specific T cells in the liver of patients with SVALI. Therefore, we aimed to characterise the immune infiltrate in a liver
Sarp Uzun +11 more
wiley +1 more source
Extrahepatic Replication and Genomic Signatures of the Hepatitis E Virus in the Kidney
Liver International, Volume 45, Issue 7, July 2025.ABSTRACT Introduction The hepatitis E virus (HEV; species Paslahepevirus balayani) is a common human pathogenic and zoonotic virus that can cause both acute fulminant and chronic hepatitis. Despite its reputation as a hepatotropic virus, HEV infection is also associated with a number of extrahepatic diseases, including kidney disorders.
Avista Wahid +28 more
wiley +1 more source
Hospitalisations With Cryoglobulin‐Related Diseases in Spain Over 25 Years
Liver International, Volume 45, Issue 7, July 2025.ABSTRACT Background The epidemiology of cryoglobulinemia in Spain has likely changed following the widespread adoption of direct‐acting antivirals (DAAs) since 2015 for the treatment of hepatitis C virus (HCV) infection, the principal cause of mixed cryoglobulinemia (MC).
Mario Martín‐Portugués +9 more
wiley +1 more source
Considerations for hepatitis B as part of a combination vaccine
, 2001 David P. Greenberg
openalex +1 more source
Plant Biotechnology Journal, Volume 23, Issue 7, Page 2570-2582, July 2025.Summary Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus causing COVID‐19, has been spreading and mutating globally despite the expedited approval of many commercial vaccines. Therefore, developing safe, effective and affordable vaccines remains essential to meet the global demand, particularly in developing countries.
Li Song +14 more
wiley +1 more source
Attitudes of the Population Toward Vaccines During the COVID‐19 Pandemic: The PROACTIVE Study
Public Health Nursing, Volume 42, Issue 4, Page 1485-1494, July/August 2025.ABSTRACT Background Vaccination is a vital strategy to prevent infectious diseases and reduce mortality globally. However, vaccine hesitancy threatens these efforts, especially highlighted during the COVID‐19 pandemic. Understanding factors influencing vaccination decisions is crucial for improving public health strategies.
Michela Calzolari +8 more
wiley +1 more source
Management of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: consensus statement
Medical Journal of Australia, Volume 222, Issue 11, Page 571-578, June 2025.Abstract Introduction Buruli ulcer, caused by Mycobacterium ulcerans, is increasing in incidence and spreading to new areas in southeast Australia. With increasing experience and emerging evidence, this consensus statement considers contemporary data to provide up‐to‐date recommendations to clinicians who may encounter this disease.
Stephen Muhi +15 more
wiley +1 more source